Effectiveness and Cost-Effectiveness of Dialectical Behaviour Therapy for Self-Harming Patients with Personality Disorder: A Pragmatic Randomised Controlled Trial

被引:102
|
作者
Priebe, Stefan [1 ]
Bhatti, Nyla [2 ]
Barnicot, Kirsten
Bremner, Stephen
Gaglia, Amy [2 ]
Katsakou, Christina [2 ]
Molosankwe, Iris [3 ]
McCrone, Paul [3 ]
Zinkler, Martin
机构
[1] Queen Mary Univ London, Unit Social & Community Psychiat, Barts & London Sch Med & Dent, Newham Ctr Mental Hlth, London E13 8SP, England
[2] E London NHS Fdn Trust, London, England
[3] Kings Coll London, Inst Psychiat, London WC2R 2LS, England
基金
美国国家卫生研究院;
关键词
Dialectical behaviour therapy; Borderline personality disorder; Self-harm; Cost-effectiveness; TREATMENT COMPLETION; RATING-SCALE; HEALTH-CARE; REAL-WORLD; FOLLOW-UP; DSM-IV; WOMEN; PSYCHOTHERAPY; METAANALYSIS; DIRECTIONS;
D O I
10.1159/000338897
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: A primary goal of dialectical behaviour therapy (DBT) is to reduce self-harm, but findings from empirical studies are inconclusive. The aim of this study was to assess the effectiveness and cost-effectiveness of DBT in reducing self-harm in patients with personality disorder. Methods: Participants with a personality disorder and at least 5 days of self-harm in the previous year were randomised to receive 12 months of either DBT or treatment as usual (TAU). The primary outcome was the frequency of days with self-harm; secondary outcomes included borderline personality disorder symptoms, general psychiatric symptoms, subjective quality of life, and costs of care. Results: Forty patients each were randomised to DBT and TAU. In an intention-to-treat analysis, there was a statistically significant treatment by time interaction for self-harm (incidence rate ratio 0.91, 95% CI 0.89-0.92, p < 0.001). For every 2 months spent in DBT, the risk of self-harm decreased by 9% relative to TAU. There was no evidence of differences on any secondary outcomes. The economic analysis revealed a total cost of a mean of 5,685 GBP (6,786 EUR) in DBT compared to a mean of 3,754 GBP (4,481 EUR) in TAU, but the difference was not significant (95% CI -603 to 4,599 GBP). Forty-eight per cent of patients completed DBT. They had a greater reduction in self-harm compared to dropouts (incidence rate ratio 0.78, 95% CI 0.76-0.80, p < 0.001). Conclusions: DBT can be effective in reducing self-harm in patients with personality disorder, possibly incurring higher total treatment costs. The effect is stronger in those who complete treatment. Future research should explore how to improve treatment adherence. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:356 / 365
页数:10
相关论文
共 50 条
  • [41] Cost-effectiveness of child caries management: a randomised controlled trial (FiCTION trial)
    Tara Homer
    Anne Maguire
    Gail V. A. Douglas
    Nicola P. Innes
    Jan E. Clarkson
    Nina Wilson
    Vicky Ryan
    Elaine McColl
    Mark Robertson
    Luke Vale
    BMC Oral Health, 20
  • [42] Cost-effectiveness of child caries management: a randomised controlled trial (FiCTION trial)
    Homer, Tara
    Maguire, Anne
    Douglas, Gail V. A.
    Innes, Nicola P.
    Clarkson, Jan E.
    Wilson, Nina
    Ryan, Vicky
    McColl, Elaine
    Robertson, Mark
    Vale, Luke
    BMC ORAL HEALTH, 2020, 20 (01)
  • [43] Clinical effectiveness and cost-effectiveness of Structured Psychological Support for people with probable personality disorder in mental health services in England: study protocol for a randomised controlled trial
    Crawford, Mike J.
    Leeson, Verity C.
    Evans, Rachel
    Goulden, Nia
    Weaver, Tim
    Trumm, Aile
    Barrett, Barbara M.
    Khun-Thompson, Fiona
    Pandya, Snehal P.
    Saunders, Kate E.
    Lamph, Gary
    Woods, David
    Smith, Harriet
    Greenall, Toby
    Nicklin, Victoria
    Barnicot, Kirsten
    BMJ OPEN, 2024, 14 (06):
  • [44] The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial
    Brabyn, Sally
    Araya, Ricardo
    Barkham, Michael
    Bower, Peter
    Cooper, Cindy
    Duarte, Ana
    Kessler, David
    Knowles, Sarah
    Lovell, Karina
    Littlewood, Elizabeth
    Mattock, Richard
    Palmer, Stephen
    Pervin, Jodi
    Richards, David
    Tallon, Debbie
    White, David
    Walker, Simon
    Worthy, Gillian
    Gilbody, Simon
    HEALTH TECHNOLOGY ASSESSMENT, 2016, 20 (89) : 1 - +
  • [45] Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trial
    Slade, Mike
    Rennick-Egglestone, Stefan
    Robinson, Clare
    Newby, Chris
    Elliott, Rachel A.
    Ali, Yasmin
    Yeo, Caroline
    Glover, Tony
    Gavan, Sean P.
    Paterson, Luke
    Pollock, Kristian
    Priebe, Stefan
    Thornicroft, Graham
    Keppens, Jeroen
    Smuk, Melanie
    Franklin, Donna
    Walcott, Rianna
    Harrison, Julian
    Robotham, Dan
    Bradstreet, Simon
    Gillard, Steve
    Cuijpers, Pim
    Farkas, Marianne
    Ben-Zeev, Dror
    Repper, Julie
    Kotera, Yasuhiro
    Roe, James
    Llewellyn-Beardsley, Joy
    Ng, Fiona
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
  • [46] Effectiveness and cost-effectiveness of embedded simulation in occupational therapy clinical practice education: study protocol for a randomised controlled trial
    Imms, Christine
    Chu, Eli Mang Yee
    Guinea, Stephen
    Sheppard, Loretta
    Froude, Elspeth
    Carter, Rob
    Darzins, Susan
    Ashby, Samantha
    Gilbert-Hunt, Susan
    Gribble, Nigel
    Nicola-Richmond, Kelli
    Penman, Merrolee
    Gospodarevskaya, Elena
    Mathieu, Erin
    Symmons, Mark
    TRIALS, 2017, 18
  • [47] Effectiveness and cost-effectiveness of embedded simulation in occupational therapy clinical practice education: study protocol for a randomised controlled trial
    Christine Imms
    Eli Mang Yee Chu
    Stephen Guinea
    Loretta Sheppard
    Elspeth Froude
    Rob Carter
    Susan Darzins
    Samantha Ashby
    Susan Gilbert-Hunt
    Nigel Gribble
    Kelli Nicola-Richmond
    Merrolee Penman
    Elena Gospodarevskaya
    Erin Mathieu
    Mark Symmons
    Trials, 18
  • [48] Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
    Romeo, Renee
    Knapp, Martin
    Hellier, Jennifer
    Dewey, Michael
    Ballard, Clive
    Baldwin, Robert
    Bentham, Peter
    Burns, Alistair
    Fox, Chris
    Holmes, Clive
    Katona, Cornelius
    Lawton, Claire
    Lindesay, James
    Livingston, Gill
    McCrae, Niall
    Moniz-Cook, Esme
    Murray, Joanna
    Nurock, Shirley
    O'Brien, John
    Poppe, Michaela
    Thomas, Alan
    Walwyn, Rebecca
    Wilson, Kenneth
    Banerjee, Sube
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (02) : 121 - 128
  • [49] Cost-effectiveness of a lifestyle intervention for hypertension: An open randomised controlled trial
    Martikainen, J. A.
    Kastarinen, M.
    Puska, P.
    Nissinen, A.
    VALUE IN HEALTH, 2006, 9 (06) : A340 - A340
  • [50] Effectiveness and cost-effectiveness of a loyalty scheme for physical activity behaviour change maintenance: results from a cluster randomised controlled trial
    Ruth F. Hunter
    Jennifer M. Murray
    Aisling Gough
    Jianjun Tang
    Christopher C. Patterson
    David P. French
    Emma McIntosh
    Yiqiao Xin
    Frank Kee
    International Journal of Behavioral Nutrition and Physical Activity, 15